We are live on ! Find out more
TENX icon

Tenax Therapeutics

9 hedge funds and large institutions have $2.04M invested in Tenax Therapeutics in 2019 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

297% more capital inflows, than outflows

Capital inflows: $999K | Capital outflows: $252K

0% more funds holding

Funds holding: 9 → 9 (0)

0% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 3

18.61% less ownership

Funds ownership: 35% → 16.39% (-19%)

50% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 2

Holders
9
Holders Change
–
Holders Change %
0%
% of All Funds
0.19%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
1
Reduced
2
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

TENX Hedge Fund Activity: Q1 2019 in Review

9 of the 4,635 institutional investors tracked by Wall St. Rank reported a position in Tenax Therapeutics (TENX) for Q1 2019, worth a combined $2.04M — up 227% from $622K a quarter earlier.

Fund positioning in TENX was balanced in Q1 2019: 3 funds opened new positions, 3 closed out, 1 added to existing stakes and 2 trimmed.

The largest buyer was BlackRock, opening a new position worth an estimated $853K. The largest seller was Sabby Management, exiting entirely with an estimated $131K sold.

  • 9 institutional investors held Tenax Therapeutics (TENX) as of Q1 2019, unchanged from Q4 2018.
  • Funds reported $2.04M of Tenax Therapeutics stock for Q1 2019, up 227% quarter-over-quarter.
  • 3 funds opened new Tenax Therapeutics positions in Q1 2019 and 3 closed out, a net change of 0 holders.
  • The largest Tenax Therapeutics buyer in Q1 2019 was BlackRock, an estimated $853K added.
  • The largest Tenax Therapeutics seller in Q1 2019 was Sabby Management, an estimated $131K sold.

Based on aggregated 13F filings for Q1 2019.